Published November 15, 2025 | Version v1
Journal article Open

Cardiometabolic risk factors for admission to the intensive care unit

Authors/Creators

  • 1. Centro Latinoamericano de Estudios Epidemiológicos y Salud Social, Cuenca, Ecuador.
  • 2. Centro Latinoamericano de Estudios Epidemiológicos y Salud Social, Cuenca, Ecuador
  • 3. Universidad Católica de Cuenca, Grupo de Investigación, Salud, Ciencia, Innovación "ISCI", Cuenca, Ecuador
  • 4. Universidad Bolivariana del Ecuador, Guayas, Ecuador
  • 5. Universidad Bolivariana del Ecuador, Guayas, Ecuador.

Description

The increasing prevalence of cardiometabolic conditions like hypertension, diabetes mellitus, and obesity is a major public health concern. These conditions are linked to several complications and comorbidities associated with hospital admission, longer length of stay, and higher healthcare costs. It has been proven that cardiometabolic risk factors (CMRF) are tightly linked to poorer clinical outcomes and higher mortality rates. However, assessing whether their impact on intensive care unit (ICU) admission is significant is a matter of debate. Although the prevalence of CMRF in the ICU is indeed significantly higher than that of the general population, no studies have been able to establish them as independent risk factors for ICU admission outside the context of COVID-19 cases. On the other hand, CMRF increase the prevalence of life-threatening conditions like congestive heart failure, chronic kidney disease, acute myocardial infarction, stroke, and many other entities that are indeed correlated with ICU admission. Nonetheless, the attributable risk for ICU admission in these cases may lie in the complications, and not the underlying CMRF properly. This review aims to analyze the evidence regarding the impact of CMRF on the rates of ICU admission to assess their utility as predictive factors for ICU hospitalization.

Files

1 r Cardiometabolic risk factors for.pdf

Files (214.2 kB)

Name Size Download all
md5:8be13fdc2015d15c715f5633f91e3c64
214.2 kB Preview Download

Additional details

References

  • Santosa A, Wall S, Fottrell E, Högberg U, Byass P. The development and experience of epidemiological transition theory over four decades: a systematic review. Glob Health Action. 2014 May 15;7:10.3402/gha.v7.23574.
  • Forouzanfar MH, Afshin A, Alexander LT, Anderson HR, Bhutta ZA, Biryukov S, et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016 Oct 8;388(10053):1659–724.
  • Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet Lond Engl. 2012 Dec 15;380(9859):2095–128.
  • Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update From the GBD 2019 Study. J Am Coll Cardiol. 2020 Dec 22;76(25):2982–3021.
  • Miranda JJ, Carrillo-Larco RM, Ferreccio C, Hambleton IR, Lotufo PA, Nieto-MartSínez R, et al. Trends in cardiometabolic risk factors in the Americas between 1980 and 2014: a pooled analysis of population-based surveys. Lancet Glob Health. 2020 Jan 1;8(1):e123–33.
  • Pogodina A, Rychkova L, Kravtzova O, Klimkina J, Kosovtzeva A. Cardiometabolic Risk Factors and Health-Related Quality of Life in Adolescents with Obesity. Child Obes. 2017 Dec;13(6):499–506.
  • Braffett BH, Bebu I, El ghormli L, Cowie CC, Sivitz WI, Pop-Busui R, et al. Cardiometabolic Risk Factors and Incident Cardiovascular Disease Events in Women vs Men With Type 1 Diabetes. JAMA Netw Open. 2022 Sep 8;5(9):e2230710.
  • Bakhtiyari M, Kazemian E, Kabir K, Hadaegh F, Aghajanian S, Mardi P, et al. Contribution of obesity and cardiometabolic risk factors in developing cardiovascular disease: a population-based cohort study. Sci Rep. 2022 Jan 28;12(1):1544.
  • Cook DJ, Webb S, Proudfoot A. Assessment and management of cardiovascular disease in the intensive care unit. Heart. 2022 Mar;108(5):397–405.
  • Boerma LM, Reijners EPJ, Hessels RAPA, V Hooft MAA. Risk factors for unplanned transfer to the intensive care unit after emergency department admission. Am J Emerg Med. 2017 Aug;35(8):1154–8.
  • Naqvi IH, Mahmood K, Ziaullaha S, Kashif SM, Sharif A. Better prognostic marker in ICU - APACHE II, SOFA or SAP II! Pak J Med Sci. 2016;32(5):1146–51.
  • Pellathy TP, Pinsky MR, Hravnak M. ICU Scoring Systems. Crit Care Nurse. 2021 Aug 1;41(4):54–64.
  • Lambden S, Laterre PF, Levy MM, Francois B. The SOFA score—development, utility and challenges of accurate assessment in clinical trials. Crit Care. 2019 Nov 27;23(1):374.
  • Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020 Apr;16(4):223–37.
  • WANG G, FANG J, AYALA C. Hypertension-associated hospitalizations and costs in the United States, 1979–2006. Blood Press. 2014 Apr;23(2):126–33.
  • Pinna G, Pascale C, Fornengo P, Arras S, Piras C, Panzarasa P, et al. Hospital Admissions for Hypertensive Crisis in the Emergency Departments: A Large Multicenter Italian Study. PLoS ONE. 2014 Apr 2;9(4):e93542.
  • Kjeldsen SE. Hypertension and cardiovascular risk: General aspects. Pharmacol Res. 2018 Mar;129:95–9.
  • Dantas RC de O, da Silva JPT, Dantas DC de O, Roncalli ÂG. Factors associated with hospital admissions due to hypertension. Einstein. 2018 Sep 11;16(3):eAO4283.
  • Qian Z, Li Z, Peng J, Gao Q, Cai S, Xu X. Association between hypertension and prognosis of patients with COVID-19: A systematic review and meta-analysis. Clin Exp Hypertens N Y N 1993. 2022 Jul 4;44(5):451–8.
  • Du Y, Zhou N, Zha W, Lv Y. Hypertension is a clinically important risk factor for critical illness and mortality in COVID-19: A meta-analysis. Nutr Metab Cardiovasc Dis. 2021 Mar 10;31(3):745–55.
  • Geng L, He C, Kan H, Zhang K, Mao A, Zhang C, et al. The association between blood pressure levels and mortality in critically ill patients with COVID-19 in Wuhan, China: a case-series report. Hypertens Res. 2021 Mar;44(3):368–70.
  • Roncon L, Zuin M, Zuliani G, Rigatelli G. Patients with arterial hypertension and COVID-19 are at higher risk of ICU admission. BJA Br J Anaesth. 2020 Aug;125(2):e254–5.
  • Xiong TY, Huang FY, Liu Q, Peng Y, Xu YN, Wei JF, et al. Hypertension is a risk factor for adverse outcomes in patients with coronavirus disease 2019: a cohort study. Ann Med. 2020 Oct 2;52(7):361–6.
  • Kim L, Garg S, O'Halloran A, Whitaker M, Pham H, Anderson EJ, et al. Risk Factors for Intensive Care Unit Admission and In-hospital Mortality Among Hospitalized Adults Identified through the US Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET). Clin Infect Dis Off Publ Infect Dis Soc Am. 2021 May 4;72(9):e206–14.
  • Shayganfar A, Sami R, Sadeghi S, Dehghan M, Khademi N, Rikhtehgaran R, et al. Risk factors associated with intensive care unit (ICU) admission and in-hospital death among adults hospitalized with COVID-19: a two-center retrospective observational study in tertiary care hospitals. Emerg Radiol. 2021 Aug 1;28(4):691–7.
  • McFarlane E, Linschoten M, Asselbergs FW, Lacy PS, Jedrzejewski D, Williams B. The impact of pre-existing hypertension and its treatment on outcomes in patients admitted to hospital with COVID-19. Hypertens Res. 2022 May;45(5):834–45.
  • Nystrom F, Wijkman M, Fredriksson M, Stenestrand U. HIGH BLOOD PRESSURE AT ADMISSION TO THE INTENSIVE CARE UNIT FOR CHEST PAIN CONFERS A LOW LONG-TERM TOTAL MORTALITY: PP.15.68. J Hypertens. 2010 Jun;28:e269.
  • Picariello C, Lazzeri C, Attanà P, Chiostri M, Gensini GF, Valente S. The Impact of Hypertension on Patients with Acute Coronary Syndromes. Int J Hypertens. 2011 Jun 22;2011:563657.
  • Bangalore S, Qin J, Sloan S, Murphy SA, Cannon CP, PROVE IT-TIMI 22 Trial Investigators. What is the optimal blood pressure in patients after acute coronary syndromes?: Relationship of blood pressure and cardiovascular events in the PRavastatin OR atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction (PROVE IT-TIMI) 22 trial. Circulation. 2010 Nov 23;122(21):2142–51.
  • Wartenberg KE, Wang X, Muñoz-Venturelli P, Rabinstein AA, Lavados PM, Anderson CS, et al. Intensive Care Unit Admission for Patients in the INTERACT2 ICH Blood Pressure Treatment Trial: Characteristics, Predictors, and Outcomes. Neurocrit Care. 2017 Jun;26(3):371–8.
  • Knight JB, Lebovitz EE, Gelzinis TA, Hilmi IA. Preoperative risk factors for unexpected postoperative intensive care unit admission: A retrospective case analysis. Anaesth Crit Care Pain Med. 2018 Dec;37(6):571–5.
  • Teck J. Diabetes-Associated Comorbidities. Prim Care. 2022 Jun;49(2):275–86.
  • Ma CX, Ma XN, Guan CH, Li YD, Mauricio D, Fu SB. Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management. Cardiovasc Diabetol. 2022 May 14;21(1):74.
  • Osuagwu UL, Xu M, Piya MK, Agho KE, Simmons D. Factors associated with long intensive care unit (ICU) admission among inpatients with and without diabetes in South Western Sydney public hospitals using the New South Wales admission patient data collection (2014–2017). BMC Endocr Disord. 2022 Jan 20;22(1):27.
  • Kastora S, Patel M, Carter B, Delibegovic M, Myint PK. Impact of diabetes on COVID-19 mortality and hospital outcomes from a global perspective: An umbrella systematic review and meta-analysis. Endocrinol Diabetes Metab. 2022 May;5(3):e00338.
  • Roncon L, Zuin M, Rigatelli G, Zuliani G. Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome. J Clin Virol Off Publ Pan Am Soc Clin Virol. 2020 Jun;127:104354.
  • Lei M, Lin K, Pi Y, Huang X, Fan L, Huang J, et al. Clinical Features and Risk Factors of ICU Admission for COVID-19 Patients with Diabetes. J Diabetes Res. 2020 Dec 15;2020:e5237840.
  • Siegelaar SE, Hickmann M, Hoekstra JB, Holleman F, DeVries JH. The effect of diabetes on mortality in critically ill patients: a systematic review and meta-analysis. Crit Care. 2011;15(5):R205.
  • Whitcomb BW, Pradhan EK, Pittas AG, Roghmann MC, Perencevich EN. Impact of admission hyperglycemia on hospital mortality in various intensive care unit populations. Crit Care Med. 2005 Dec;33(12):2772–7.
  • Carrasco-Sánchez FJ, López-Carmona MD, Martínez-Marcos FJ, Pérez-Belmonte LM, Hidalgo-Jiménez A, Buonaiuto V, et al. Admission hyperglycaemia as a predictor of mortality in patients hospitalized with COVID-19 regardless of diabetes status: data from the Spanish SEMI-COVID-19 Registry. Ann Med. 2021 Jan 1;53(1):103–16.
  • Freire AX, Bridges L, Umpierrez GE, Kuhl D, Kitabchi AE. Admission Hyperglycemia and Other Risk Factors as Predictors of Hospital Mortality in a Medical ICU Population. Chest. 2005 Nov;128(5):3109–16.
  • Robba C, Bilotta F. Admission hyperglycemia and outcome in ICU patients with sepsis. J Thorac Dis. 2016 Jul;8(7):E581–3.
  • Roberts GW, Quinn SJ, Valentine N, Alhawassi T, O'Dea H, Stranks SN, et al. Relative Hyperglycemia, a Marker of Critical Illness: Introducing the Stress Hyperglycemia Ratio. J Clin Endocrinol Metab. 2015 Dec;100(12):4490–7.
  • Koraćević G, Zdravković M. WHAT IS STRESS HYPERGLYCEMIA? A SUGGESTION FOR AN IMPROVEMENT OF ITS DEFINITION. Acta Endocrinol Buchar. 2021;17(4):548–51.
  • Bellaver P, Schaeffer AF, Dullius DP, Viana MV, Leitão CB, Rech TH. Association of multiple glycemic parameters at intensive care unit admission with mortality and clinical outcomes in critically ill patients. Sci Rep. 2019 Dec 6;9(1):18498.
  • Bar-Or D, Rael LT, Madayag RM, Banton KL, Tanner A, Acuna DL, et al. Stress Hyperglycemia in Critically Ill Patients: Insight Into Possible Molecular Pathways. Front Med [Internet]. 2019 [cited 2022 Dec 6];6. Available from: https://www.frontiersin.org/articles/10.3389/fmed.2019.00054
  • Barmanray RD, Cheuk N, Fourlanos S, Greenberg PB, Colman PG, Worth LJ. In-hospital hyperglycemia but not diabetes mellitus alone is associated with increased in-hospital mortality in community-acquired pneumonia (CAP): a systematic review and meta-analysis of observational studies prior to COVID-19. BMJ Open Diabetes Res Care. 2022 Jul 1;10(4):e002880.
  • Cui C, Zhou M, Cheng L, Ye T, Zhang Y, Zhu F, et al. Admission hyperglycemia as an independent predictor of long‐term prognosis in acute myocardial infarction patients without diabetes: A retrospective study. J Diabetes Investig. 2021 Jul;12(7):1244–51.
  • Kerby JD, Griffin RL, MacLennan P, Rue LW. Stress-induced hyperglycemia, not diabetic hyperglycemia, is associated with higher mortality in trauma. Ann Surg. 2012 Sep;256(3):446–52.
  • Dickerson RN, Andromalos L, Brown JC, Correia MITD, Pritts W, Ridley EJ, et al. Obesity and critical care nutrition: current practice gaps and directions for future research. Crit Care. 2022 Sep 20;26(1):283.
  • Decruyenaere A, Steen J, Colpaert K, Benoit DD, Decruyenaere J, Vansteelandt S. The obesity paradox in critically ill patients: a causal learning approach to a casual finding. Crit Care. 2020 Aug 5;24(1):485.
  • Schetz M, De Jong A, Deane AM, Druml W, Hemelaar P, Pelosi P, et al. Obesity in the critically ill: a narrative review. Intensive Care Med. 2019 Jun;45(6):757–69.
  • Földi M, Farkas N, Kiss S, Zádori N, Váncsa S, Szakó L, et al. Obesity is a risk factor for developing critical condition in COVID-19 patients: A systematic review and meta-analysis. Obes Rev. 2020;21(10):e13095.
  • jögren L, Stenberg E, Thuccani M, Martikainen J, Rylander C, Wallenius V, et al. Impact of obesity on intensive care outcomes in patients with COVID-19 in Sweden—A cohort study. PLOS ONE. 2021 Oct 13;16(10):e0257891.
  • Akinnusi ME, Pineda LA, El Solh AA. Effect of obesity on intensive care morbidity and mortality: a meta-analysis. Crit Care Med. 2008 Jan;36(1):151–8.